MWR
GSK icon

McAdams Wright Ragen’s GSK GSK Stock Holding History

McAdams Wright Ragen’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.81M Buy
66,219
+1,245
+2% +$76.3K 0.21% 104
2014
Q2 		$4.34M Sell
64,974
-8,388
-11% -$568K 0.24% 88
2014
Q1 		$4.9M Sell
73,362
-1,699
-2% -$115K 0.3% 78
2013
Q4 		$5.01M Sell
75,061
-270
-0.4% -$17.5K 0.33% 81
2013
Q3 		$4.72M Sell
75,331
-2,027
-3% -$130K 0.37% 75
2013
Q2 		$4.83M Buy
+77,358
New +$4.91M 0.39% 78

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

McAdams Wright Ragen's GSK Position: Q3 2014 in Review

McAdams Wright Ragen increased its GSK (GSK) stake by 1.9% in Q3 2014, buying an estimated $76.3K and bringing the position to 66,219 shares worth $3.81M. The position accounts for 0.21% of the portfolio, ranked #104.

McAdams Wright Ragen first reported a position in GSK in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.01M in Q4 2013. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • McAdams Wright Ragen held 66,219 shares of GSK worth $3.81M as of Q3 2014.
  • McAdams Wright Ragen bought 1,245 GSK shares in Q3 2014, an estimated $76.3K.
  • GSK made up 0.21% of McAdams Wright Ragen's portfolio in Q3 2014, its #104 holding.
  • McAdams Wright Ragen first reported a position in GSK in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's GSK position peaked at $5.01M in Q4 2013.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.